ABSTRACT
Four areas of MMPI use and development toward the year 2000 and beyond are discussed. First, although the MMPI–2 booklet is a clear improvement, we will continue to need to use both profiles, the MMPI–2 for normative purposes and the MMPI profile for pattern interpretation. Applying MMPI expectations to MMPI–2 profiles is a violation of Meehl’s basic actuarial prediction concepts. Secondly, as psychologists begin prescribing medications, we may be able to substantially refine drug choices. Thirdly, the measurement of socioeconomic status levels appears to be the major, missing moderator variable in MMPI/MMPI–2 interpretation. Lastly, an effective and positive MMPI/MMPI–2 feedback paradigm is discussed that fits well within the managed care context.
